Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
---|---|---|---|
USD 13.10 Billion | USD 23.54 Billion | 6.04% | 2024 |
FrequentlyAsked Questions
The global needle-free diabetes care market is expected to grow due to the need for pain-free, convenient glucose monitoring and insulin delivery, along with rising diabetes prevalence.
According to a study, the global needle-free diabetes care market size was worth around USD 13.10 Billion in 2024 and is expected to reach USD 23.54 Billion by 2034.
The global needle-free diabetes care market is expected to grow at a CAGR of 6.04% during the forecast period.
North America is expected to dominate the needle-free diabetes care market over the forecast period.
Leading players in the global needle-free diabetes care market include Anatres Pharma, European Pharma Group, Johnson & Johnson, Injex UK Ltd, Bioject Medical Technologies Inc., PharmaJet, MannKind Corporation, Tandem Diabetes Care, Medtronic, Pancreum LLC, Glide Pharmaceutical Technologies Ltd, Zogenix, Akra Dermojet, Echo Therapeutics, 3M, Medical International Technology Inc., National Medical Products Inc., PenJet Corporation, among others.
The report explores crucial aspects of the needle-free diabetes care market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed